Computational Exploration of Isatin Derivatives for InhA Inhibition in Tuberculosis: Molecular Docking, MD Simulations and ADMET Insights
Considering the aforementioned, isatin derivatives represents a novel framework for creating targeted InhA inhibitors during anti-<i>TB</i> therapy. However, experimental validations and in-depth analyses are crucial to confirm efficacy and safety of these derivatives as potential InhA inhibitors for TB treatment.
Authors
- Vaishali Patel (ORCID: https://orcid.org/0000-0003-2812-207X)
- Abhay Dharamsi (ORCID: https://orcid.org/0000-0001-5401-3120)
- Rati Kailash Prasad Tripathi (ORCID: https://orcid.org/0000-0002-9699-4155)
Institutions
- Assam University (IN)
- Parul University (IN)
Publication Details
- Journal
- Current Computer - Aided Drug Design
- Published
- 2024-09-16
- DOI
- https://doi.org/10.2174/0115734099333313240909103833
- Citations
- 3
- Primary Topic
- Cancer therapeutics and mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.70